BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23815605)

  • 1. Investigational drugs for pruritus.
    Benecke H; Lotts T; Ständer S
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1167-79. PubMed ID: 23815605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of pruritus.
    Ständer S; Weisshaar E
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):335-45. PubMed ID: 22870909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel drugs for the treatment of chronic pruritus.
    Pereira MP; Ständer S
    Expert Opin Investig Drugs; 2018 Dec; 27(12):981-988. PubMed ID: 30426802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic pruritus: targets, mechanisms and future therapies.
    Pogatzki-Zahn E; Marziniak M; Schneider G; Luger TA; Ständer S
    Drug News Perspect; 2008 Dec; 21(10):541-51. PubMed ID: 19221635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus.
    Ständer S; Yosipovitch G
    Br J Dermatol; 2019 Nov; 181(5):932-938. PubMed ID: 31016733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are new treatment concepts in systemic itch?
    Kremer AE
    Exp Dermatol; 2019 Dec; 28(12):1485-1492. PubMed ID: 31452276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New investigational drugs for the treatment of neuropathic pain.
    Sałat K; Kowalczyk P; Gryzło B; Jakubowska A; Kulig K
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1093-104. PubMed ID: 24896842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for the treatment of pruritus.
    Ständer S; Weisshaar E; Raap U
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):515-21. PubMed ID: 26027744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research in practice: substance P antagonism in chronic pruritus.
    Lotts T; Ständer S
    J Dtsch Dermatol Ges; 2014 Jul; 12(7):557-9. PubMed ID: 24862239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel investigational therapies for treating pulmonary arterial hypertension.
    Sardana M; Moll M; Farber HW
    Expert Opin Investig Drugs; 2015; 24(12):1571-96. PubMed ID: 26484967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modern systemic therapy for pruritus].
    Metz M; Pereira MP
    Hautarzt; 2020 Jul; 71(7):518-524. PubMed ID: 32399670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for pruritus in the elderly: a review of treatment developments.
    Pereira MP; Ständer S
    Expert Opin Pharmacother; 2018 Apr; 19(5):443-450. PubMed ID: 29493371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel investigational therapeutics for panic disorder.
    Perna G; Schruers K; Alciati A; Caldirola D
    Expert Opin Investig Drugs; 2015 Apr; 24(4):491-505. PubMed ID: 25539284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic pruritus: From pathophysiology to drug design.
    Martins MS; Almeida IF; Cruz MT; Sousa E
    Biochem Pharmacol; 2023 Jun; 212():115568. PubMed ID: 37116666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational cytokine-targeted therapies for ulcerative colitis.
    Monteleone G; Pallone F; Caprioli F
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1123-32. PubMed ID: 23802627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinued anxiolytic drugs (2009 - 2014).
    Mandrioli R; Mercolini L
    Expert Opin Investig Drugs; 2015 Apr; 24(4):557-73. PubMed ID: 25557457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy for chronic pruritus-light at the end of a long tunnel?].
    Pereira MP; Salzmann S; Ständer S; Staubach P; Metz M
    Internist (Berl); 2020 Oct; 61(10):1076-1086. PubMed ID: 32676722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational drugs under development for the treatment of PTSD.
    Ragen BJ; Seidel J; Chollak C; Pietrzak RH; Neumeister A
    Expert Opin Investig Drugs; 2015 May; 24(5):659-72. PubMed ID: 25773140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-analgesic effects of opioids: peripheral opioid receptors as promising targets for future anti-pruritic therapies.
    Reich A; Szepietowski JC
    Curr Pharm Des; 2012; 18(37):6021-4. PubMed ID: 22747545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.